RxDoctor Payments Data

Heather Nguyen, NP

Gerontology · Huntington Beach, CANPI 1497125447

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.2% of the total across 346 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 23.3% — the pattern of someone who eats at a lot of different presentations. Among gerontology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$10,343in general payments, 2019–2025

Across 346 payments — averaging $29.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Amgen$861
  • UCB, Inc.$773
  • E.r. Squibb & Sons, L.L.C.$746
  • Incyte Corporation$686
  • Fresenius Kabi USA, LLC$673
  • plus $4K from 23 others

What the payments were for

  • Food & beverage$10,05197%
  • Education$2923%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,343 in reported general payments places this provider in the 95th percentile of 348 gerontology providers in California.

See all gerontology providers in California

Medicare billing

Part B allowed, 2024
$18,520
Medicare patients
73
Services billed
341

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OtezlaApremilast13$61,718
Tacrolimus59$9,606
Fluocinonide55$2,497
Calcipotriene12$1,601
Ketoconazole55$1,225
Betamethasone Dipropionate31$1,186
Triamcinolone Acetonide74$437
Clindamycin Phosphate11$267
Mupirocin33$184
Doxycycline Hyclate11$150
Hydrocortisone16$62

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AmgenOtezla$861$61,71813 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 348 gerontology providers in California.

Other gerontology in Huntington Beach

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →